JPH01117811A - External preparation - Google Patents

External preparation

Info

Publication number
JPH01117811A
JPH01117811A JP62275221A JP27522187A JPH01117811A JP H01117811 A JPH01117811 A JP H01117811A JP 62275221 A JP62275221 A JP 62275221A JP 27522187 A JP27522187 A JP 27522187A JP H01117811 A JPH01117811 A JP H01117811A
Authority
JP
Japan
Prior art keywords
acid
skin
diacylglycerin
formula
fatty acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP62275221A
Other languages
Japanese (ja)
Other versions
JPH0338242B2 (en
Inventor
Masahiko Asahi
正彦 旭
Takashi Komori
隆 小森
Toshiyuki Suzuki
敏幸 鈴木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP62275221A priority Critical patent/JPH01117811A/en
Priority to AT88308927T priority patent/ATE130036T1/en
Priority to DE3854664T priority patent/DE3854664T2/en
Priority to EP88308927A priority patent/EP0319126B1/en
Priority to EP95200097A priority patent/EP0658629A1/en
Priority to MYPI88001237A priority patent/MY103776A/en
Publication of JPH01117811A publication Critical patent/JPH01117811A/en
Publication of JPH0338242B2 publication Critical patent/JPH0338242B2/ja
Priority to US07/977,894 priority patent/US5461170A/en
Priority to HK172896A priority patent/HK172896A/en
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11CFATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C3/00Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
    • C11C3/04Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/64Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436Fatty acid esters
    • C12P7/6445Glycerides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02Preparations containing skin colorants, e.g. pigments
    • A61Q1/04Preparations containing skin colorants, e.g. pigments for lips
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02Preparations containing skin colorants, e.g. pigments
    • A61Q1/04Preparations containing skin colorants, e.g. pigments for lips
    • A61Q1/06Lipsticks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02Preparations containing skin colorants, e.g. pigments
    • A61Q1/10Preparations containing skin colorants, e.g. pigments for eyes, e.g. eyeliner, mascara

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

PURPOSE:To obtain an external preparation useful as skin cosmetic, hair cosmetic or drug for external use, having high skin affinity and excellent prolonging effects on moisture retention of skin, comprising a diacylglycerin containing acyl residues of a specific branched chain fatty acid and myristic acid. CONSTITUTION:The above external preparation obtained by blending an external preparation such as the above-mentioned cosmetic or drug with about 0.1-90wt.%, preferably 0.1-50wt.% diacylglycerin shown by formula I [one of R1-R3 is branched-chain fatty acid residue selected from group shown by formula II (m and n are 4-10 integer, m+n=14, having distribution with center at m=n=7), 5,7,7-trimethyl-2-(1,3,3-trimethylbutyl)-octanoic acid residue or 2- heptylundecanoic acid residue, remaining one is tetradecanoic acid (myristic acid) residue and the residue is H] as an active ingredient and having the above- mentioned effects such as good fit to the skin.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は外用剤に関し、更に詳細には特定のジアシルグ
リセリンを含有してなる皮膚親和性が高く(皮膚へのな
じみ性が良り)、かつ皮膚保湿持続効果に優れた皮膚化
粧品、毛髪化粧品、外用医薬品等の外用剤に関する。
[Detailed Description of the Invention] [Industrial Application Field] The present invention relates to an external preparation, and more specifically, it contains a specific diacylglycerin and has high skin affinity (good compatibility with the skin). The present invention also relates to external preparations such as skin cosmetics, hair cosmetics, and external medicines that have excellent long-lasting skin moisturizing effects.

〔従来の技術及びその問題点〕[Conventional technology and its problems]

正常な皮膚の角質層には通常10〜30%の水分が含ま
れており、弾力性と柔軟性が維持されているが、これが
環境条件等の原因で10%以下になると、いわゆるドラ
イスキンと呼ばれる状態になる。例えば冬期乾燥時のひ
び、あかぎれ等の症状である。
The stratum corneum of normal skin normally contains 10 to 30% water, maintaining its elasticity and flexibility, but when this drops to less than 10% due to environmental conditions, it becomes what is called dry skin. Become called. For example, symptoms such as cracks and chapping occur during dry winter months.

また、加齢とともに皮脂の分泌が減少するため皮膚が乾
燥しやす(なり、掻痒を伴い落屑が生じる老人性乾皮症
のような症状が現れてくる。
Additionally, as we age, the secretion of sebum decreases, making the skin prone to dryness and symptoms such as senile xeroderma, which causes itching and scaling.

これらを解決するための方法として、従来保湿剤を用い
て皮膚水和効果を高める方法と、油剤を用いて経皮水分
損失(T、E、W、L、)を抑制する方法があった。
As methods for solving these problems, there have conventionally been methods to enhance the skin hydration effect using humectants and methods to suppress transepidermal water loss (T, E, W, L,) using oils.

前者の例としては、グリセリン、プロピレングリコール
、ピロリドンカルボン酸ナトリウム等の保湿剤が用いら
れてきたが、これら保湿剤の作用は、いずれも皮膚に適
用した場合、その効果は一時的で持続性がなく、外部環
境条件の影響を受けやすいという欠点を有していた。
As examples of the former, moisturizers such as glycerin, propylene glycol, and sodium pyrrolidone carboxylate have been used, but when applied to the skin, the effects of these moisturizers are temporary and long-lasting. However, it had the disadvantage of being susceptible to external environmental conditions.

一方、後者の例としては、ワセリン軟膏が良く知られて
いるが、効果を高めるためには塗布量を多くしなければ
ならず、そのことにより使用中油性感、べたつきが強く
、肌へなじみにくいといった不快な感触になり、また逆
に塗布量が少ないと閉塞性が弱く持続性がないという欠
点を有していた。
On the other hand, Vaseline ointment is a well-known example of the latter, but in order to increase its effectiveness, it is necessary to apply a large amount, resulting in an oily feeling, stickiness, and difficulty in absorbing the skin. It has an unpleasant feel, and conversely, if the amount applied is too small, the occlusion property is weak and it is not long-lasting.

〔問題点を解決するための手段〕[Means for solving problems]

本発明者らはこうした実情に鑑み、皮膚親和性が高く、
かつ皮膚保湿持続効果に優れた外用剤を得るべく鋭意研
究した結果、特定の分岐飽和脂肪酸とミリスチン酸(テ
トラデカン酸)とのアシル残基を有するジアシルグリセ
リンを配合することにより、肌へのなじみ性が良く、皮
膚保湿持続効果に優れていることを見出し、本発明を完
成した。
In view of these circumstances, the present inventors have found that
As a result of intensive research to obtain an external preparation with excellent long-lasting skin moisturizing effects, we have developed a formulation that blends with diacylglycerin, which has acyl residues of specific branched saturated fatty acids and myristic acid (tetradecanoic acid), to improve its compatibility with the skin. The present invention was completed based on the discovery that the skin moisturizing effect is good and has an excellent long-lasting skin moisturizing effect.

即ち本発明は、 次の一般式(Hで表されるジアシルグ
リセリンを含有することを特徴とする外用剤を提供する
ものである。
That is, the present invention provides an external preparation characterized by containing diacylglycerin represented by the following general formula (H).

CHt  OR+ CHORt          ・・・(1)CH2−
0−R3 〔式中、R+、Rz、lhのうち1つは(i)次式で表
されるメチル分岐イソステアリン酸残基、 CH3(CH2) −CH(CHz) 1lCO−CI
(3 (式中、■及びnはそれぞれ4〜10の整数で、m+n
=14であり、n+=n−7を中心とする分布を有する
。) (u)54.7  )リメチル−2−(1,3,3−ト
リメチルブチル)−オクタン酸残基、 (iii)2−へブチルウンデカン酸残基よりなる群か
ら選ばれた分岐飽和脂肪酸残基を、1つはテトラデカン
酸残基を、残余は水素を示す、〕 本発明に用いる一般式(1)で示されるジアシルグリセ
リンは1分子中に前記の如き炭素数18の分岐飽和脂肪
酸残基(イソステアリン酸残基)とテトラデカン酸残基
を有するものであり、例えば以下の方法で合成すること
ができる。
CHt OR+ CHORt...(1) CH2-
0-R3 [wherein, one of R+, Rz, and lh is (i) a methyl branched isostearic acid residue represented by the following formula, CH3(CH2) -CH(CHz) 1lCO-CI
(3 (In the formula, ■ and n are each integers of 4 to 10, m + n
=14, and has a distribution centered at n+=n-7. ) (u)54.7) a branched saturated fatty acid residue selected from the group consisting of: (u)54.7) a remethyl-2-(1,3,3-trimethylbutyl)-octanoic acid residue; (iii) a 2-hebutylundecanoic acid residue; One group represents a tetradecanoic acid residue, and the remainder represents hydrogen.] The diacylglycerin represented by the general formula (1) used in the present invention contains in one molecule the branched saturated fatty acid residue having 18 carbon atoms as described above. (isostearic acid residue) and tetradecanoic acid residue, and can be synthesized, for example, by the following method.

(1)  グリセリンの脂肪酸による直接エステル化。(1) Direct esterification of glycerin with fatty acids.

炭素数18の分岐飽和脂肪酸及びテトラデカン酸(ミリ
スチン酸)とグリセリンから通常のアシルグリセリンを
製造する方法によって製造される。例えば、上記の分岐
飽和脂肪酸及びミリスチン酸とグリセリンを等モル配合
し、200〜230℃に加熱し、生成する水を減圧下で
除くことによって、これらのアシルグリセリン混合物が
生成する。この生成物を蒸留もしくはカラムクロマト処
理することによって、ジアシルグリセリンフラクション
を得ることができる。ただし、このジアシルグリセリン
はランダム混合物であるため、つまり、分岐飽和脂肪酸
残基のみから成るジアシルグリセリン、分岐飽和脂肪酸
残基とミリスチン酸残基から成るジアシルグリセリン及
びミリスチン酸残基のみから成るジアシルグリセリンの
混合物であるため、これらの融点差を利用して、更にヘ
キサン等の溶剤を用いた再結晶化法により目的とする本
発明のジアシルグリセリンを得る。
It is produced by a conventional method for producing acylglycerin from a branched saturated fatty acid having 18 carbon atoms, tetradecanoic acid (myristic acid), and glycerin. For example, a mixture of these acylglycerols is produced by blending equimolar amounts of the branched saturated fatty acids and myristic acid and glycerin, heating the mixture to 200 to 230°C, and removing the produced water under reduced pressure. A diacylglycerol fraction can be obtained by subjecting this product to distillation or column chromatography. However, this diacylglycerin is a random mixture; that is, diacylglycerin consisting only of branched saturated fatty acid residues, diacylglycerin consisting of branched saturated fatty acid residues and myristic acid residues, and diacylglycerin consisting only of myristic acid residues. Since it is a mixture, the desired diacylglycerin of the present invention can be obtained by a recrystallization method using a solvent such as hexane by utilizing the difference in melting point.

ここで本発明のジアシルグリセリンの製造に用いられる
炭素数18の分岐飽和脂肪酸は、石油化学工業原料又は
油脂化学工業原料より容易に得られる。
The branched saturated fatty acid having 18 carbon atoms used for producing the diacylglycerin of the present invention can be easily obtained from petrochemical raw materials or oleochemical raw materials.

即ち、5.7.7−ドリメチルー2−(1,3,3−ト
リ、メチルブチル)−オクタン酸は、イソブチレン2量
体のオキソ反応により炭素数9の分岐アルデヒドとし、
次いでこのアルデヒドのアルドール縮合により炭素数1
8の分岐不飽和アルデヒドとし、次いで水素添加、酸化
することにより製造することができ、これは例えば日産
化学−より市販されている。2−へブチルウンデカン酸
はノニルアルコールをゲルベ反応(Guerbet r
eaction)に付し、次いで酸化することにより製
造することができ、これは例えば三菱化成■より市販さ
れている。
That is, 5.7.7-dolimethyl-2-(1,3,3-tri,methylbutyl)-octanoic acid is converted into a branched aldehyde having 9 carbon atoms by the oxo reaction of isobutylene dimer,
Then, by aldol condensation of this aldehyde, the number of carbon atoms is 1.
It can be produced by preparing a branched unsaturated aldehyde of No. 8, followed by hydrogenation and oxidation, and this is commercially available, for example, from Nissan Chemical. 2-Hebutylundecanoic acid is produced by converting nonyl alcohol into the Guerbet reaction.
reaction) and then oxidation, and is commercially available from, for example, Mitsubishi Kasei.

また、メチル分岐イソステアリン酸は、例えばオレイン
酸のダイマー製造時の副産物として得られるもので〔例
えばJ、 Amer、 Oil Chell。
Methyl branched isostearic acid is obtained, for example, as a by-product during the production of oleic acid dimer [for example, J. Amer, Oil Chell.

Soc、、 51.522(1974) ) 、例えば
米国エメリー社などから市販されている。
Soc., 51.522 (1974)), and is commercially available, for example, from Emery Company, USA.

(2)脂肪酸の反応性誘導体とモノグリセライドとの反
応。
(2) Reaction of reactive derivatives of fatty acids with monoglycerides.

より有利な製造法として分岐飽和脂肪酸もしくはミリス
チン酸のいずれか一方をより反応性の高い誘導体に導き
エステル化することもできる。反応性の高い誘導体の一
つは、脂肪酸の酸ハライドであり、これを経る場合の好
ましい具体例においては、先ず、原料分岐飽和脂肪酸に
、この分岐飽和脂肪酸1モル当たり1〜5モル、好まし
くは1〜2モルの塩化チオニル、臭化チオニル、三塩化
リン等のハロゲン化試薬を0〜100″C1好ましくは
20〜80°Cで反応せしめて酸ハライドに導く。片 
As a more advantageous production method, either branched saturated fatty acid or myristic acid can be converted into a more reactive derivative and then esterified. One of the highly reactive derivatives is an acid halide of a fatty acid, and in a preferred example of this process, first, 1 to 5 mol, preferably 1 to 5 mol per mol of the branched saturated fatty acid, is added to the raw branched saturated fatty acid. 1 to 2 moles of a halogenating reagent such as thionyl chloride, thionyl bromide, phosphorus trichloride, etc. are reacted at 0 to 100"C, preferably 20 to 80°C, to form an acid halide.
.

やミリスチン酸1モルとグリセリン1モルとを200〜
230″Cに加熱し、生成する水を減圧下で除くことに
よってミリストイルグリセリンが得られる。このものを
、分子蒸留することによって、モノミリストイルグリセ
リンを得る。そこで前述した分岐飽和脂肪酸ハライドと
、分岐飽和脂肪酸ハライド1モル当たり0.5〜3モル
、好ましくは1〜1.5モルのモノミリストイルグリセ
リンとを、酸ハライドに対して1〜3モル、好ましくは
1〜1.5モルのピリジン、キノリン等の脱ハロゲン化
水素剤を用い、例えばベンゼン、トルエン、キシレン、
ヘキサン等の゛適当な不活性溶剤中(酸ハライドに対し
て1〜10倍容量、好ましくは3〜5倍容it)で50
〜100°C1好ましくは60〜80℃で加熱撹拌しな
がら反応させる。生成するハロゲン化水素アミン塩を除
去したアシルグリセリンを、分子蒸留もしくはカラムク
ロマト処理することによって目的とする分岐飽和脂肪酸
残基とミリスチン酸残基とを含むジアシルグリセリンを
得ることができる。
200 ~ 1 mole of myristic acid and 1 mole of glycerin
Myristoylglycerin is obtained by heating to 230"C and removing the produced water under reduced pressure. By molecularly distilling this, monomyristoylglycerin is obtained. Therefore, the above-mentioned branched saturated fatty acid halide and branched saturated 0.5 to 3 moles, preferably 1 to 1.5 moles of monomyristoylglycerin per mole of fatty acid halide, and 1 to 3 moles, preferably 1 to 1.5 moles of pyridine, quinoline, etc. relative to the acid halide. For example, benzene, toluene, xylene,
50 in a suitable inert solvent such as hexane (1 to 10 times the volume, preferably 3 to 5 times the volume of the acid halide).
The reaction is carried out while heating and stirring at ~100°C, preferably 60-80°C. The desired diacylglycerin containing branched saturated fatty acid residues and myristic acid residues can be obtained by subjecting the produced acylglycerin from which the hydrogen halide amine salt has been removed to molecular distillation or column chromatography.

(3)  リパーゼを用いる方法。(3) Method using lipase.

更に有利な製造方法として反応性の高い誘導体を経るこ
となく、リパーゼを用いて製造することができる。先ず
、分岐飽和脂肪酸1モルとグリセリン1モルとを200
〜230℃に加熱し、生成する水を減圧下で除くことに
よって、分岐飽和脂肪酸残基を有するアシルグリセリン
を得て、分子蒸留を通して分岐飽和脂肪酸残基を有する
モノアシルグリセリンを得る。このモノアシルグリセリ
ンとミリスチン酸を等モル量配合し、リパーゼを触媒と
してエステル化反応を行うことによって目的とする分岐
飽和脂肪酸残基とミリスチン酸残基とを含むジアシルグ
リセリンが得られる。エステル化の程度に応じて、後処
理として分子蒸留を行う。例えばミリスチン酸のエステ
ル化率が低い場合は、残余のミリスチン酸及びモノアシ
ルグリセリンを除去する必要がある。
As a more advantageous production method, it can be produced using lipase without using highly reactive derivatives. First, 1 mol of branched saturated fatty acid and 1 mol of glycerin are mixed into 200
Acylglycerin with branched saturated fatty acid residues is obtained by heating to ~230°C and the water produced is removed under reduced pressure, and monoacylglycerin with branched saturated fatty acid residues is obtained through molecular distillation. The desired diacylglycerol containing branched saturated fatty acid residues and myristic acid residues is obtained by blending equimolar amounts of this monoacylglycerol and myristic acid and performing an esterification reaction using lipase as a catalyst. Depending on the degree of esterification, molecular distillation is carried out as a post-treatment. For example, if the esterification rate of myristic acid is low, it is necessary to remove residual myristic acid and monoacylglycerol.

また、トリアジルグリセリンの副生も分子蒸留カラムク
ロマトにより除去することができる。リパーゼを触媒と
して用いる場合、α−位選択性を有するリパーゼあるい
は部分グリセリドに選択的なリパーゼは最も有効である
Moreover, the by-product of triazylglycerin can also be removed by molecular distillation column chromatography. When using a lipase as a catalyst, a lipase having α-position selectivity or a lipase selective for partial glycerides is most effective.

本発明のジアシルグリセリンの外用剤における配合量は
第1表に示した通り、剤型に応じて幅広く変動し得るも
のの、概ね0.1〜90重量%、好ましくは0.1〜5
0重量%の範囲である。
As shown in Table 1, the amount of diacylglycerin in the external preparation of the present invention can vary widely depending on the dosage form, but is generally 0.1 to 90% by weight, preferably 0.1 to 5% by weight.
It is in the range of 0% by weight.

一方、本発明で使用される水以外の他の原料成分として
は、通常、外用剤に適用される油分、界面活性剤、多価
アルコール類を含む保湿剤、各種薬効剤、防腐剤、香料
等、はとんどの成分が挙げ・られ、その中から目的、用
途、剤型等に応じて適宜選択され、配合される。例えば
、油分については、ステアリン酸、ミリスチン酸、セタ
ノール、ステアリルアルコール、コレステロール、ワセ
リン等に代表される固体脂とスクワラン、コレステリル
イソステアレート、ホホバ油、オリーブ油、シカプリン
酸ネオペンチルグリコール、流動パラフィン等に代表さ
れる液体脂がある。一方、多価アルコールについては、
グリセリン、1.3−ブチレングリコール、プロピレン
グリコール、ジプロピレングリコール、ポリエチレング
リコールなどが挙げられる。更に界面活性剤については
、ポリオキシエチレン硬化しマシ油、ソルビタン脂肪酸
エステル、ポリオキシエチレンソルビタン脂肪酸エステ
ル、ポリエチレングリコール脂肪酸エステル、アルキル
グリセリルエーテル、脂肪酸塩、アルキルリン酸塩など
が挙げられる。
On the other hand, raw materials other than water used in the present invention include oils, surfactants, humectants containing polyhydric alcohols, various medicinal agents, preservatives, fragrances, etc. that are usually applied to external preparations. Most of the ingredients are listed, and they are appropriately selected and blended depending on the purpose, use, dosage form, etc. For example, regarding oil content, solid fats such as stearic acid, myristic acid, cetanol, stearyl alcohol, cholesterol, petrolatum, etc., squalane, cholesteryl isostearate, jojoba oil, olive oil, neopentyl glycol capriate, liquid paraffin, etc. There is a typical liquid fat. On the other hand, regarding polyhydric alcohol,
Examples include glycerin, 1,3-butylene glycol, propylene glycol, dipropylene glycol, and polyethylene glycol. Furthermore, examples of the surfactant include polyoxyethylene hardened mustard oil, sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyethylene glycol fatty acid ester, alkyl glyceryl ether, fatty acid salt, alkyl phosphate, and the like.

また、本発明の対象となる外用剤としては、軟膏、クリ
ーム、乳液、ローション等であり、通常、後記の第1表
に示す配合量が好適である。
Further, external preparations to which the present invention is applied include ointments, creams, emulsions, lotions, etc., and the blending amounts shown in Table 1 below are usually suitable.

なお、第1表において配合割合は重量%である。In addition, in Table 1, the blending ratio is in weight %.

第  1  表 〔発明の効果〕 本発明に用いる一般式(1)で示されるジアシルグリセ
リンは室温で液状を呈し、酸化安定性に優れ、分解も極
めて低く、低刺激で皮膚、毛髪に対する感触も優れたも
のである。即ち、単に液状のジアシルグリセリンを得る
には脂肪酸残基にすレイン酸等の不飽和脂肪酸を用いる
か、オクタン酸等の短鎖脂肪酸を用いればよいが、不飽
和脂肪酸のみを用いると酸化安定性が、短鎖脂肪酸のみ
を用いると刺激性が問題になる。
Table 1 [Effects of the Invention] The diacylglycerin represented by the general formula (1) used in the present invention is liquid at room temperature, has excellent oxidative stability, has extremely low decomposition, is low in irritation, and has an excellent feel on the skin and hair. It is something that In other words, to simply obtain liquid diacylglycerin, it is sufficient to use an unsaturated fatty acid such as oleic acid as the fatty acid residue, or a short chain fatty acid such as octanoic acid, but if only unsaturated fatty acids are used, the oxidative stability However, when only short chain fatty acids are used, irritation becomes a problem.

これに対し、1分子中に炭素数18の分岐飽和脂肪酸残
基とテトラデカン酸残基を同時に有する本発明のジアシ
ルグリセリンではこれらの問題がない。
In contrast, the diacylglycerin of the present invention, which simultaneously contains a branched saturated fatty acid residue having 18 carbon atoms and a tetradecanoic acid residue in one molecule, does not have these problems.

かかるジアシルグリセリンを含有する本発明の外用剤は
結晶性成分を含まないので肌へのなじみ性がよく、また
皮膚保湿持続効果に優れている。
Since the external preparation of the present invention containing such diacylglycerin does not contain a crystalline component, it has good compatibility with the skin and has an excellent long-lasting skin moisturizing effect.

〔実施例〕〔Example〕

以下に本発明の実施例を示し本発明を更に詳細に説明す
るが、本発明はこれらの実施例に限定されるものではな
い。
EXAMPLES The present invention will be explained in more detail by showing examples below, but the present invention is not limited to these examples.

尚、併せて、分岐飽和脂肪酸及びミリスチン酸のモノア
シルグリセリンと分岐飽和脂肪酸ハライドの製造法を参
考例として、また本発明に係わる分岐飽和脂肪酸残基と
ミリスチン酸残基を有するジアシルグリセリンの製造法
を合成例として示す。
In addition, the method for producing monoacylglycerol of branched saturated fatty acids and myristic acid and the branched saturated fatty acid halide is also used as a reference example, and the method for producing diacylglycerol having branched saturated fatty acid residues and myristic acid residues according to the present invention. is shown as a synthesis example.

参考例1 温度計、還流冷却器、滴下漏斗、撹拌器を備えた容!2
1の反応容器に、イソステアリン酸(5,7,7−)リ
メチル−2−(1,3,3−)リメチルブチル)オクタ
ン酸、日産化学■製)568g(2,0モル)を仕込ん
だ、撹拌しながら、窒素ガス通気下で、滴下漏斗より塩
化チオニル286g (2,4モル)を室温で滴下した
。塩化チオニルの滴下が進行するに従って、反応混合物
は、無色、淡黄色、黒褐色に着色し、同時にガスの発生
が認められた。塩化チオニルの滴下中、反応混合物の温
度を室温に保った。塩化チオニルを約3時間を要して滴
下した後、油浴にて反応混合物を60〜70°Cに約3
時間保った。ガスの発生が殆ど認められなくなった事を
確認後、減圧下で低沸点物を留去した後、減圧蒸留を行
った。
Reference example 1 A container equipped with a thermometer, reflux condenser, dropping funnel, and stirrer! 2
568 g (2.0 mol) of (5,7,7-)limethyl-2-(1,3,3-)limethylbutyl)octanoic acid (manufactured by Nissan Chemical Co., Ltd.) was charged into the reaction vessel No. 1, and stirred. Meanwhile, 286 g (2.4 mol) of thionyl chloride was added dropwise from a dropping funnel at room temperature under nitrogen gas ventilation. As the dropwise addition of thionyl chloride progressed, the reaction mixture turned colorless, pale yellow, and blackish brown, and at the same time, gas generation was observed. The temperature of the reaction mixture was kept at room temperature during the dropwise addition of thionyl chloride. After adding thionyl chloride dropwise over a period of about 3 hours, the reaction mixture was heated to 60-70°C in an oil bath for about 3 hours.
Saved time. After confirming that almost no gas generation was observed, low-boiling substances were distilled off under reduced pressure, and then vacuum distillation was performed.

112〜120°C10,1〜0.3mmHgの留分5
B8g(収量97%)を得た。このものは5.7.7−
ドリメチルー2− (1,3,3−)リメチルブチル)
オクタン酸クロライドであった。
112-120°C10,1-0.3mmHg fraction 5
8 g (yield 97%) of B was obtained. This one is 5.7.7-
Dolimethyl-2-(1,3,3-)limethylbutyl)
It was octanoyl chloride.

IRスペクトル(液膜法) 2970、2920.2875.1795 (C=O伸
縮) 、 1480゜1390.1370,1260,
1210,995,930,790゜710,600c
m−’ H’−NMRスペクトル(CC14溶媒):C0,9(
s、24H,Cjh  ) ■ 参考例2 参考例1で用いたものと同じ装置を備えた容Malの反
応容器を用い、イソステアリン酸(下記式で表されるメ
チル分岐脂肪酸であり、米国エメリー社の、Emery
 875イソステアリン酸) 568g (2,0モル
)−に塩化チオニル520g(4,4モル)を参考例1
と同様に反応させた。
IR spectrum (liquid film method) 2970, 2920.2875.1795 (C=O stretching), 1480° 1390.1370, 1260,
1210,995,930,790°710,600c
m-'H'-NMR spectrum (CC14 solvent): C0,9(
s, 24H, Cjh) ■ Reference Example 2 Using a reaction vessel with a volume of Mal equipped with the same equipment as that used in Reference Example 1, isostearic acid (a methyl branched fatty acid represented by the following formula, manufactured by Emery Co., Ltd. in the United States) was prepared. , Emery
Reference Example 1: 520 g (4.4 mol) of thionyl chloride was added to 568 g (2.0 mol) of 875 isostearic acid.
reacted in the same way.

Cl5(CHz)−CH(CHz)lICOOHCH3 (式中m及びnはそれぞれ4〜10の整数で、m+n・
14であり、m=n= 7を中心とする分布を有する。
Cl5(CHz)-CH(CHz)lICOOHCH3 (in the formula, m and n are each integers of 4 to 10, m+n・
14, with a distribution centered at m=n=7.

)反応後、減圧下で低沸点物を留去して約230gの塩
化チオニルと思われる低沸点物を回収した。次いで減圧
蒸留により、153〜b〜3.OmmHgの留分454
 g (収率75%)を得た。
) After the reaction, low-boiling substances were distilled off under reduced pressure to recover about 230 g of low-boiling substances believed to be thionyl chloride. Then, by vacuum distillation, 153-b-3. OmmHg fraction 454
g (yield 75%) was obtained.

このものはメチル分岐イソステアリン酸クロライドであ
った。
This was methyl branched isostearic acid chloride.

IRスペクトル(液膜法) 2950、2920.2550.1800 (C・0伸
縮) 、 1460゜1400、13B0.950.7
20.680.590cm−’H’−NMRスペクトル
(CC14溶媒):C0,6””1.0 (m、 C1
hCHz−及び−C3−)0匹3 1.0〜1.5 (m、  CHt  )1.5〜2.
0 (m、 −Cll−)CH3 2,77(t、 CIIzCOCl )参考例3 温度計、窒素キャピラリー、還流冷却器(水分離管材)
、撹拌器を備えた容量21の反応容器に、2−へブチル
ウンデカン酸568g (2,0モル)と精製グリセリ
ン184g (2,0モル)、水酸化カルシウム1.2
gを仕込み、窒素ガス通気下で230〜240℃にてエ
ステル化を行った。
IR spectrum (liquid film method) 2950, 2920.2550.1800 (C・0 stretching), 1460°1400, 13B0.950.7
20.680.590cm-'H'-NMR spectrum (CC14 solvent): C0,6""1.0 (m, C1
hCHz- and -C3-) 0 animals 3 1.0-1.5 (m, CHt) 1.5-2.
0 (m, -Cll-)CH3 2,77 (t, CIIzCOCl) Reference example 3 Thermometer, nitrogen capillary, reflux condenser (water separation tube material)
In a 21-volume reaction vessel equipped with a stirrer, 568 g (2.0 mol) of 2-hebutylundecanoic acid, 184 g (2.0 mol) of purified glycerin, and 1.2 g of calcium hydroxide were added.
g was charged, and esterification was performed at 230 to 240°C under nitrogen gas ventilation.

約10時間後、水の生成が殆ど認められなくなった事を
確認し、減圧蒸留に切り替え、210〜220”C/1
5〜25mmHgの条件下で未反応のグリセリンを除去
した。留出グリセリンがほとんど認められなくなった後
、反応混合物を薄膜式分子蒸留器にて蒸留を行い、17
0〜175°c 10.03〜0.O5mmHgの留分
246gを得た。このものは2−ヘプチルウンデカン酸
のモノアシルグリセリンであった。
After about 10 hours, it was confirmed that almost no water was produced, and the vacuum distillation was switched to 210-220"C/1.
Unreacted glycerin was removed under conditions of 5 to 25 mmHg. After almost no distilled glycerin was observed, the reaction mixture was distilled using a thin-film molecular distiller, and 17
0~175°c 10.03~0. 246 g of a fraction with an O of 5 mmHg was obtained. This was a monoacylglycerol of 2-heptylundecanoic acid.

IRスペクトル(液膜法) 3440  (0旧中縮)  、  2960. 29
10. 2860. 1740(C=0伸縮) 、 1
470.1370.1160.740cm−’H’−N
MRスペクトル(CC1,溶媒):C0,9(t、68
.Cl、−) 1.1〜1.6 (n+、 28H,−Cl2−)旦 
0 2.7 (s、 2H,−0−H) 3.5〜4.2 (m、5H,CHz  0−及びンC
旦−0−)水酸基価 311.8  (計算値312.
9)参考例4 参考例3で用いたものと同じ装置を備えた容量21の反
応容器にミリスチン酸458g (2,0モル)と精製
グリセリン184g (2,0モル)、水酸化カルシウ
ム0.9gを仕込み、窒素ガス通気下で230〜240
°Cにて約8時間エステル化反応を行った。次に減圧蒸
留に切り替え210〜220”C/15〜25mdgの
条件下で未反応のグリセリンを除去した。留出グリセリ
ンが認められなくなった後、反応混合物を薄膜式分子蒸
留器にて蒸留を行い、195〜200℃、0.03〜0
.05ma+Hgの留分230gを得た。このものはモ
ノミリストイルグリセリンであった。
IR spectrum (liquid film method) 3440 (0 former abbreviation), 2960. 29
10. 2860. 1740 (C=0 expansion/contraction), 1
470.1370.1160.740cm-'H'-N
MR spectrum (CC1, solvent): C0,9 (t, 68
.. Cl, -) 1.1 to 1.6 (n+, 28H, -Cl2-)
0 2.7 (s, 2H, -0-H) 3.5-4.2 (m, 5H, CHz 0- and nC
Dan-0-) Hydroxyl value 311.8 (calculated value 312.
9) Reference Example 4 In a reaction vessel with a capacity of 21 equipped with the same equipment as used in Reference Example 3, 458 g (2.0 mol) of myristic acid, 184 g (2.0 mol) of purified glycerin, and 0.9 g of calcium hydroxide were added. 230-240 under nitrogen gas aeration.
The esterification reaction was carried out at °C for about 8 hours. Next, we switched to vacuum distillation and removed unreacted glycerin under the conditions of 210-220"C/15-25mdg. After no more distilled glycerin was observed, the reaction mixture was distilled using a thin film molecular distillation device. , 195-200℃, 0.03-0
.. 230 g of a fraction of 0.05 ma+Hg was obtained. This was monomyristoylglycerin.

水酸基価370.3  (計算値371.0)合成例1 温度計、滴下漏斗、還流冷却器、撹拌器を備えた3!の
反応容器に、参考例4で得られたモノミリストイルグリ
セリン303g(1モル)、ベンゼン10100O、ピ
リジン87g (1,1モル)をこの順で加えた0反応
部合物を撹拌しながら窒素ガス通気下で油浴で50°C
に加熱し、次いで滴下漏斗より参考例1で得られた5、
7.7− !−リメチルー2− (1,3,3−)ジエ
チルブチル)オクタン酸クロライド291g (0,9
6モル)を、反応混合物の温度を約50℃に保ちながら
、約3時間を要して滴下した。滴下終了後、60〜80
℃に加熱して約5時間撹拌を続けた。反応生成物中のピ
リジン塩酸塩の白色沈澱物を濾過により除去し、得られ
た濾液を減圧下で溶媒留去させた後、0.5〜0.7m
mHgの減圧下で190〜200″Cで約5時間加熱し
、僅かに残存する酸クロライドを完全に除去した。得ら
れた生成物は、モノミリストイルグリセリン1分子に対
して5.7.7−)ジエチル−2−(1,3,3−)ジ
エチルブチル)オクタン酸が1分子乃至2分子アシル化
されたジアシルグリセ1Jン及びトリアジルグリセリン
そして未反応のモノミリストイルグリセリンの混合物で
ある。
Hydroxyl value: 370.3 (calculated value: 371.0) Synthesis Example 1 Equipped with a thermometer, dropping funnel, reflux condenser, and stirrer 3! 303 g (1 mol) of monomyristoylglycerin obtained in Reference Example 4, 10,100 O of benzene, and 87 g (1.1 mol) of pyridine were added in this order to a reaction vessel. The reaction mixture was stirred and nitrogen gas was bubbled through it. 50°C in an oil bath below
5 obtained in Reference Example 1 from a dropping funnel.
7.7-! -limethyl-2- (1,3,3-)diethylbutyl)octanoic acid chloride 291g (0,9
6 mol) was added dropwise over a period of about 3 hours while maintaining the temperature of the reaction mixture at about 50°C. After the completion of dripping, 60 to 80
℃ and continued stirring for about 5 hours. The white precipitate of pyridine hydrochloride in the reaction product was removed by filtration, and the resulting filtrate was subjected to solvent distillation under reduced pressure.
The product was heated at 190-200"C for about 5 hours under reduced pressure of mHg to completely remove the slight remaining acid chloride. The resulting product had a molecular weight of 5.7.7 - ) A mixture of diacylglycerin and triazylglycerin in which one or two molecules of diethyl-2-(1,3,3-)diethylbutyl)octanoic acid are acylated and unreacted monomyristoylglycerin.

この混合物をカラムクロマト(ワコーゲルB−10(和
光純薬工業製)、ヘキサン/ジエチルエーテル=707
30)にて処理し、ジアシルグリセリンフラクション3
60gを得た。このものは無色透明な液体で5.7.7
−ドリメチルー2−(1゜3.3−)ジエチルブチル)
オクタン酸とミリスチン酸とを脂肪酸残基とするジアシ
ルグリセリンである。
This mixture was subjected to column chromatography (Wakogel B-10 (manufactured by Wako Pure Chemical Industries), hexane/diethyl ether = 707
30) and diacylglycerin fraction 3
60g was obtained. This substance is a colorless and transparent liquid. 5.7.7
-drimethyl-2-(1゜3.3-)diethylbutyl)
It is diacylglycerin with octanoic acid and myristic acid as fatty acid residues.

IRスペクトル(液膜法) 3500 (OH伸1i&) 、 2960.2930
.2850. 1740(C=0伸縮) 、 1465
.1365.1160.720cm −’H’−NMR
スペクトル(CC14溶媒):δ2.9 (s、 18
.−OH) 4.0〜4.5 (m、 4H,−CI□−〇−)5.
1 (L IHI /C且−0H)酸価 0.1(計算
値O) 水酸基価 98.0 (計算値98.6)合成例2 合成例1で用いたものと同じ装置を備えた容量3!の反
応容器に参考例4で得られたモノミリストイルグリセリ
ン303g(1モル)、ベンゼン1500@Z、ピリジ
ン100g (1,27モル)をこの順で加えた。これ
を撹拌しながら、窒素ガス通気下、油浴で50°Cに加
熱し、滴下漏斗より参考例2で得られたメチル分岐イソ
ステアリン酸クロライド291g (0,96モル)を
滴下した。滴下終了後、反応混合物を50℃に約3時間
、さらに70〜80’Cに約8時間保った。この加熱処
理によりエステル化反応は完全に進行し、反応混合物中
に酸クロライドは全く含まれていない事がIRスペクト
ルにより確認された。合成例1と同様に処理し、無色透
明な液体であるメチル分岐イソステアリン酸とミリスチ
ン酸とを脂肪酸残基とするジアシルグリセリン372g
を得た。
IR spectrum (liquid film method) 3500 (OH Shin 1i&), 2960.2930
.. 2850. 1740 (C=0 expansion/contraction), 1465
.. 1365.1160.720cm -'H'-NMR
Spectrum (CC14 solvent): δ2.9 (s, 18
.. -OH) 4.0 to 4.5 (m, 4H, -CI□-〇-)5.
1 (L IHI /C and -0H) Acid value 0.1 (calculated value O) Hydroxyl value 98.0 (calculated value 98.6) Synthesis example 2 Capacity 3 equipped with the same equipment as used in synthesis example 1 ! 303 g (1 mol) of monomyristoylglycerin obtained in Reference Example 4, 1500@Z of benzene, and 100 g (1.27 mol) of pyridine were added to the reaction vessel in this order. While stirring, the mixture was heated to 50°C in an oil bath under nitrogen gas flow, and 291 g (0.96 mol) of methyl branched isostearic acid chloride obtained in Reference Example 2 was added dropwise from the dropping funnel. After the addition was complete, the reaction mixture was kept at 50°C for about 3 hours and then at 70-80'C for about 8 hours. As a result of this heat treatment, the esterification reaction proceeded completely, and it was confirmed by the IR spectrum that no acid chloride was contained in the reaction mixture. 372 g of diacylglycerin prepared in the same manner as in Synthesis Example 1 and containing methyl branched isostearic acid and myristic acid as fatty acid residues, which is a colorless and transparent liquid.
I got it.

IRスペクトル(液膜法) 3480 (OH伸縮) 、 2955.2930.2
850.1740(C=0伸縮) 、 1465.13
65.1160.720cm”H’−NMRスヘクトル
(Cc−14溶媒):δ0.9 (m、98.  CH
3) 1.2〜1.6 (m、 49H,−C且2−9−釦)
2.3 (m、 48.  CHz Co )   1
2.9 (s、  LH,−0)1) 4.0〜4.5 (a+、 4H,−C且10)5.1
 (m、 LH,、>CH−OH)酸価 0.l(計算
値O) 水酸基価 97.4 (計算値98.6)合成例3 温度計、還流冷却器、撹拌器を備えた容量21の反応容
器に参考例3で得た2−へブチルウンデカン酸のモノア
シルグリセリン359g(1モル)、ミリスチン酸27
4g (1,2モル)、市販リパーゼ製剤Lipozy
me 3A (陰イオン交換樹脂に固定化したムコール
・ミーハイ(Mucor m1e−hei)起源のリパ
ーゼ、ノボインダストリー・A・S社製)80gを加え
た。50°Cに加熱し、100〜300mmHHの減圧
下で5時間撹拌しエステル化反応を行った。反応終了後
、リパーゼ製剤を濾過し、濾液の反応物を190〜19
5°C,0,03〜0.O5mmHgの条件下で薄膜式
分子蒸留器を用い蒸留し、過剰のミリスチン酸及び未反
応のモノアシルグリセリンを除去し、目的とする2−へ
ブチルウンデカン酸とミリスチン酸を残基とするジアシ
ルグリセリン501gを得た。
IR spectrum (liquid film method) 3480 (OH stretching), 2955.2930.2
850.1740 (C=0 expansion/contraction), 1465.13
65.1160.720cm"H'-NMR spectrum (Cc-14 solvent): δ0.9 (m, 98. CH
3) 1.2-1.6 (m, 49H, -C and 2-9-button)
2.3 (m, 48. Hz Co) 1
2.9 (s, LH, -0) 1) 4.0 to 4.5 (a+, 4H, -C and 10) 5.1
(m, LH,, >CH-OH) Acid value 0. l (calculated value O) Hydroxyl value 97.4 (calculated value 98.6) Synthesis Example 3 2-Hebutylundecane obtained in Reference Example 3 was placed in a reaction vessel with a capacity of 21 equipped with a thermometer, a reflux condenser, and a stirrer. Acid monoacylglycerin 359g (1 mol), myristic acid 27
4g (1,2 mol), commercially available lipase preparation Lipozy
80 g of me 3A (lipase of Mucor mle-hei origin immobilized on an anion exchange resin, manufactured by Novo Industries A.S.) was added. The mixture was heated to 50°C and stirred for 5 hours under reduced pressure of 100 to 300 mmHH to carry out an esterification reaction. After the reaction is completed, the lipase preparation is filtered, and the reaction product of the filtrate is 190-19
5°C, 0.03~0. Excess myristic acid and unreacted monoacylglycerin were distilled using a thin-film molecular distillation device under O5 mmHg conditions to remove excess myristic acid and unreacted monoacylglycerin, yielding 501 g of the desired diacylglycerin containing 2-hebutylundecanoic acid and myristic acid as residues. I got it.

IRスペクトル(液膜法) 3480 (OH伸縮) 、 2960.2930.2
850.1740(C=0伸縮) 、 1465.13
65.1160.720cm−’H’−NMRスペクト
ル(CC1a溶媒):δ0.9 (m、 98.  C
1h) 1.2〜1.6  (m、 50L  CHt  )2
.3’(m、3H1’>CHCo −1CHz  Co
  )2.7  (s、 IB、 −0H) 4.0〜4.5  (m、411.  CHz  O)
5.1 (o+、 18.  )C旦−0H)酸価 0
.1(計算値0) 水酸基価 97.1 (計算値98.6)実施例1(軟
 膏) 〈油相成分〉 ワセリン          40  重量%スクワラ
ン         10 合成例2で得た本発明の ジアシルグリセリン  20  重量%ブチルパラベン
        0.1く水相成分〉 メチルパラベン        0.2重量%グリセリ
ン        10 水             バランス上記組成の油相
成分及び水相成分を用い、下記製造法により軟膏を調製
した。
IR spectrum (liquid film method) 3480 (OH stretching), 2960.2930.2
850.1740 (C=0 expansion/contraction), 1465.13
65.1160.720cm-'H'-NMR spectrum (CC1a solvent): δ0.9 (m, 98.C
1h) 1.2~1.6 (m, 50L CHt)2
.. 3'(m, 3H1'>CHCo -1CHz Co
)2.7 (s, IB, -0H) 4.0~4.5 (m, 411.CHz O)
5.1 (o+, 18.) Cdan-0H) Acid value 0
.. 1 (calculated value 0) Hydroxyl value 97.1 (calculated value 98.6) Example 1 (ointment) <Oil phase component> Vaseline 40% by weight Squalane 10 Diacylglycerin of the present invention obtained in Synthesis Example 2 20% by weight Butylparaben 0.1% Water phase component> Methylparaben 0.2% by weight Glycerin 10% Water Balance An ointment was prepared using the oil phase component and water phase component having the above composition according to the following manufacturing method.

〈製造法〉 水にメチルパラベン、グリセリンを加えて加熱し、この
水相部を70°Cに保つ。一方、他の親油性の成分を混
合し加熱溶解し、この油相部を70゛Cにする0次いで
上記水相部にこの油相部を加えてこれらを乳化機にて乳
化する。
<Manufacturing method> Methylparaben and glycerin are added to water and heated, and the aqueous phase is maintained at 70°C. On the other hand, other lipophilic components are mixed and heated to dissolve, and the oil phase is brought to 70°C.The oil phase is then added to the aqueous phase and emulsified in an emulsifier.

乳化物を熱交換機にて終湯30°Cまで冷却した後、充
填を行うことにより、本発明の軟膏を調製した。
The ointment of the present invention was prepared by cooling the emulsion to a final temperature of 30° C. using a heat exchanger and then filling the emulsion.

得られた本発明の軟膏は、皮膚親和性が高く、かつ皮膚
保湿持続効果に優れた外用剤であった。
The obtained ointment of the present invention was an external preparation with high skin affinity and excellent long-lasting skin moisturizing effect.

実施例2(クリーム) 〈油相成分〉 ステアリン酸         2 重量%セタノール
          l コレステロール        1 スクワラン         10 ホホバ油           10 POE (40)硬化ヒマシ油     0.5セチル
リン酸         0.5モノステアリン酸ソル
ビタン  2.0ブチルパラベン        0.
1〈水相成分〉 メチルパラベン        0.2重量%グリセリ
ン        10 1.3−ブチレングリコール   5 香料      0.1 水酸化カリウム        0.1水      
       バランス上記組成の油相成分及び水相成
分を用い、下記製造法によりクリームを調製した。
Example 2 (cream) <Oil phase components> Stearic acid 2 wt% cetanol l Cholesterol 1 Squalane 10 Jojoba oil 10 POE (40) Hydrogenated castor oil 0.5 Cetyl phosphoric acid 0.5 Sorbitan monostearate 2.0 Butyl paraben 0 ..
1 <Aqueous phase components> Methylparaben 0.2% by weight Glycerin 10 1.3-Butylene glycol 5 Fragrance 0.1 Potassium hydroxide 0.1 Water
Balance A cream was prepared by the following manufacturing method using the oil phase component and water phase component having the above composition.

く製造法〉 上記水相成分を混合し、加熱溶解して水相部を70℃に
保つ、上記油相成分も同様に70’Cで加熱混合し、こ
の水相部に上記の油相部を加えてそれらを乳化機にて乳
化する。乳化物を熱交換機にて終湯30°Cまで冷却し
た後、充填を行゛うことにより、本発明のクリームを調
製した。
Production method> The above aqueous phase components are mixed, heated and dissolved, and the aqueous phase is maintained at 70°C.The above oil phase component is similarly heated and mixed at 70'C, and the above oil phase is added to the aqueous phase. and emulsify them using an emulsifying machine. The cream of the present invention was prepared by cooling the emulsion to a final temperature of 30°C using a heat exchanger and then filling the emulsion.

得られた本発明のクリームは、皮膚親和性が高く、かつ
皮膚保湿持続効果に優れた外用剤であった。
The obtained cream of the present invention was an external preparation with high skin affinity and excellent long-term skin moisturizing effect.

実施例3(乳 液) 〈油相成分〉 セタノール          1 重量%スクワラン
          5 オリーブ油          3 ホホバ油           2 POE (10)硬化ヒマシ油     1 重量%モ
ノステアリン酸ソルビタン  1 ブチルパラベン        0.1く水相成分〉 メチルパラベン        0.1重量%グリセリ
ン         2 1.3−ブチレングリコール   2 エタノール          3 香料      0.1 水             バランス上記組成の油相
成分及び水相成分を用い、実施例2と同様の方法により
乳液を調製した。
Example 3 (Emulsion) <Oil phase components> Setanol 1 wt% squalane 5 Olive oil 3 Jojoba oil 2 POE (10) Hydrogenated castor oil 1 wt% Sorbitan monostearate 1 Butylparaben 0.1 Water phase components> Methylparaben 0 .1% by weight Glycerin 2 1.3-Butylene glycol 2 Ethanol 3 Fragrance 0.1 Water Balance A milky lotion was prepared in the same manner as in Example 2 using the oil phase component and water phase component having the above composition.

得られた本発明の乳液は、皮膚親和性が高く、かつ皮膚
保湿持続効果に優れた外用剤であった。
The obtained emulsion of the present invention was an external preparation that had high skin affinity and excellent long-lasting skin moisturizing effect.

実施例4(ローション) く油相成分〉 POE (60)硬化ヒマシ油     1く水相成分
〉 乳酸     適量 乳酸ソーダ         適 量 グリセリン          3 重量%1.3−ブ
チレングリコール   1.5ポリエチレングリコール
1500  0.5エタノール          1
0 香料      0.1 水             バランス上記組成の油相
成分及び水相成分を用い、下記製造法によりローション
を調製した。
Example 4 (Lotion) Oil phase component> POE (60) Hydrogenated castor oil 1 Water phase component> Lactic acid Appropriate amount Sodium lactate Appropriate amount Glycerin 3% by weight 1.3-Butylene glycol 1.5 Polyethylene glycol 1500 0.5 Ethanol 1
0 Perfume 0.1 Water Balance A lotion was prepared by the following manufacturing method using the oil phase component and water phase component having the above composition.

く製造法〉 水にグリセリン、1.3−ブチレングリコール、ポリエ
チレングリコール1500、乳酸、乳酸ソーダ、エタノ
ールを溶解し、弱酸性(pH5〜6)にする。これにポ
リオキシエチレン硬化ヒマシ油、合成例2で得た本発明
のジアシルグリセリン、香料を溶解したものを撹拌して
本発明のローションを調製した。
Production method> Dissolve glycerin, 1.3-butylene glycol, polyethylene glycol 1500, lactic acid, sodium lactate, and ethanol in water to make it weakly acidic (pH 5 to 6). A lotion of the present invention was prepared by dissolving polyoxyethylene hydrogenated castor oil, the diacylglycerin of the present invention obtained in Synthesis Example 2, and a fragrance in this solution.

得られた本発明のローションは、皮膚親和性が高く、か
つ皮膚保湿持続効果に優れた外用剤であった。
The obtained lotion of the present invention was an external preparation with high skin affinity and excellent long-term skin moisturizing effect.

Claims (1)

【特許請求の範囲】 次の一般式( I )で表されるジアシルグリセリンを含
有することを特徴とする外用剤。 ▲数式、化学式、表等があります▼・・・( I ) 〔式中、R_1、R_2、R_3のうち1つは(i)次
式で表されるメチル分岐イソステアリン酸残基、 ▲数式、化学式、表等があります▼ (式中、m及びnはそれぞれ4〜10の整数で、m+n
=14であり、m=n=7を中心とする分布を有する。 ) (ii)5,7,7−トリメチル−2−(1,3,3−
トリメチルブチル)−オクタン酸残基、 (iii)2−ヘプチルウンデカン酸残基 よりなる群から選ばれた分岐飽和脂肪酸残基を、1つは
テトラデカン酸残基を、残余は水素を示す。〕
[Scope of Claims] An external preparation characterized by containing diacylglycerin represented by the following general formula (I). ▲There are mathematical formulas, chemical formulas, tables, etc.▼...(I) [In the formula, one of R_1, R_2, and R_3 is (i) a methyl branched isostearic acid residue represented by the following formula, ▲Mathematical formula, chemical formula , tables, etc. ▼ (In the formula, m and n are each integers from 4 to 10, and m+n
=14, and has a distribution centered at m=n=7. ) (ii) 5,7,7-trimethyl-2-(1,3,3-
(iii) branched saturated fatty acid residues selected from the group consisting of (trimethylbutyl)-octanoic acid residues, and (iii) 2-heptylundecanoic acid residues, one of which is a tetradecanoic acid residue and the rest of which are hydrogen. ]
JP62275221A 1987-10-14 1987-10-30 External preparation Granted JPH01117811A (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
JP62275221A JPH01117811A (en) 1987-10-30 1987-10-30 External preparation
AT88308927T ATE130036T1 (en) 1987-10-14 1988-09-27 METHOD FOR PRODUCING A POLYOL FATTY ACID ESTER AND GLYCERIDE MIXTURE OBTAINED THEREFROM.
DE3854664T DE3854664T2 (en) 1987-10-14 1988-09-27 Process for producing a polyol fatty acid ester and glyceride mixture obtained thereby.
EP88308927A EP0319126B1 (en) 1987-10-14 1988-09-27 Process for preparation of polyol fatty acid ester and glyceride mixture obtained
EP95200097A EP0658629A1 (en) 1987-10-14 1988-09-27 Process for preparation of polyol fatty acid ester and glyceride mixture obtained
MYPI88001237A MY103776A (en) 1987-10-14 1988-10-28 Process for preparation of polyol fatty acid ester and glyceride mixture obtained
US07/977,894 US5461170A (en) 1987-10-14 1992-11-18 Process for preparation of polyol fatty acid ester and glyceride mixture obtained
HK172896A HK172896A (en) 1987-10-14 1996-09-12 Process for preparation of polyol fatty acid ester and glyceride mixture obtained

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62275221A JPH01117811A (en) 1987-10-30 1987-10-30 External preparation

Publications (2)

Publication Number Publication Date
JPH01117811A true JPH01117811A (en) 1989-05-10
JPH0338242B2 JPH0338242B2 (en) 1991-06-10

Family

ID=17552392

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62275221A Granted JPH01117811A (en) 1987-10-14 1987-10-30 External preparation

Country Status (1)

Country Link
JP (1) JPH01117811A (en)

Also Published As

Publication number Publication date
JPH0338242B2 (en) 1991-06-10

Similar Documents

Publication Publication Date Title
EP0319126B1 (en) Process for preparation of polyol fatty acid ester and glyceride mixture obtained
JPH0459285B2 (en)
EP0028457B1 (en) Cosmetic and emulsifier composition
EP0028456B1 (en) Branched fatty acid cholesterol ester and a cosmetic composition containing the same
WO2000061097A1 (en) External preparation compositions
JPH0517399A (en) Ester derivative and cosmetics containing the same derivative
JPS58104624A (en) Emulsified composition
JPS6241202B2 (en)
JPH01117811A (en) External preparation
JPH08291045A (en) Stabilizer consisting of fluorohydrocarbon compound in emulsion
JPS63216812A (en) Skin drug for external use
JP3073813B2 (en) Cosmetics
JP2551471B2 (en) Glyceryl ether derivative and skin external preparation containing the same
JPS591407A (en) Cosmetic containing branched fatty acid cholesteryl ester
JP2691608B2 (en) Pack cosmetics
JPH0692296B2 (en) External skin preparation
JP2613142B2 (en) Water-in-oil emulsion cosmetics
JPH0763613B2 (en) Water-in-oil emulsion composition
JP3271828B2 (en) Water-in-oil emulsion cosmetics
JP2693816B2 (en) Solid powder cosmetics
JP2542009B2 (en) Liquid oil
JPH026729B2 (en)
JP2691609B2 (en) Emulsified cosmetic
JPS62181236A (en) Novel ester and cosmetic containing said ester
JP3788633B2 (en) Phosphoric acid triester and cosmetics and external preparations containing the same

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees